Algae-Derived Bioactive Compounds with Anti-Lung Cancer Potential

Mar Drugs. 2020 Apr 8;18(4):197. doi: 10.3390/md18040197.

Abstract

Lung cancer is one of the major causes of death worldwide. Natural molecules with anti-lung cancer potential are of a great interest and considered as very promising alternative to substitute or enhance the efficiency of the conventional drugs. Recently, algae as source of high value-added compounds are considered as very promising source of these bioactive molecules. These are secondary metabolites that consist mainly of derivatives of peptides, carbohydrates, and lipids with various structures. Accordingly, various mechanisms by which different algae molecules demonstrate attenuation of tumor angiogenesis were stated and discussed. The mode of action of the algae bioactives is closely related to their nature and chemical structure. Furthermore, this literature review considers the synergistic effect between microalgae bioactives and conventional drugs and discuss the economic feasibility of producing microalgae bioactives at large scale to conclude with some future perspectives related to algae-based drug discovery.

Keywords: bioactives; drug discovery; lung cancer; marine algae; mode of action; molecular target.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Biological Products / pharmacology*
  • Carbohydrates / pharmacology
  • Drug Discovery
  • Humans
  • Lipids / pharmacology
  • Lung Neoplasms / drug therapy*
  • Microalgae / chemistry
  • Peptides / pharmacology
  • Phytochemicals / chemistry
  • Phytochemicals / pharmacology*
  • Seaweed / chemistry

Substances

  • Antineoplastic Agents
  • Biological Products
  • Carbohydrates
  • Lipids
  • Peptides
  • Phytochemicals